Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy. Jiang C, Xiu Y, Yu X, Qiao K, et al. BMC Cancer 2022;22:1249.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang C, Xiu Y, Yu X, Qiao K, et al. Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy. BMC Cancer 2022;22:1249.
PMID: 36460981